ArticleHIV medicine2026

Twice-daily bictegravir during rifampicin-based tuberculosis therapy: A pragmatic alternative.

Juan Gabriel Sánchez-Cano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.